Work

Optec: A Phase 2 Study to Evaluate Outpatient Step-up Administration of Teclistamab in Patients with Relapsed/Refractory Multiple Myeloma (RRMM): Updated Results

Year: 2024

Type: conference-abstract

Source: Blood

DOI: 10.1182/blood-2024-207295

Authors: Robert Rifkin, Henning Schade, Gary Simmons, Christopher Yasenchak, Jessica Fowler, Thomas S. Lin, Lijuan Kang, Weiming Xu

Institutions: Rocky Mountain Cancer Centers, Colorado Blood Cancer Institute, Willamette Valley Cancer Institute and Research Center, Janssen Scientific Affairs (United States), Sarah Cannon

Language: English

Topic: Multiple Myeloma Research and Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4405039620

Cites:

Cited by: 8

Related to: 10